Kathleen S. Capps, See Remarks at ENANTA PHARMACEUTICALS INC (ENTA), sold 292 shares at $13.96 ($4K) on 2025-12-02, disclosed to the SEC on 2025-12-03.
Open-market sale of $4k ENTA by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.12 | 85 | $1K | 29.3% |
| 2 | $13.96 | 207 | $3K | 70.7% |
| Total | $14.01 avg | 292 | $4K | 100% |